Back
Gilead Sciences 10K Form
Buy
76
GILD
Gilead Sciences
Last Price:
$110.05
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | GILD/Gilead Sciences Quarterly |
2024-02-23 | 10K | GILD/Gilead Sciences Annual |
2023-11-07 | 10Q | GILD/Gilead Sciences Quarterly |
2023-08-04 | 10Q | GILD/Gilead Sciences Quarterly |
2023-05-03 | 10Q | GILD/Gilead Sciences Quarterly |
2023-02-22 | 10K | GILD/Gilead Sciences Annual |
Receive GILD News And Ratings
See the #1 stock for the next 7 days that we like better than GILD
GILD Financial Statistics
Sales & Book Value
Annual Sales: | $28.8B |
---|---|
Cash Flow: | $3.4B |
Price / Cash Flow: | 12.45 |
Annual Sales: | $15.44 |
Price / Book: | 6.97 |
Profitability
EPS (TTM): | 0.37000 |
---|---|
Net Income (TTM): | $480M |
Gross Margin: | $22.5B |
Return on Equity: | 2.5% |
Return on Assets: | 0.84% |
Gilead Sciences Earnings Forecast
Key Gilead Sciences Financial Ratios
-
The Gross Profit Margin over the past 34 years for GILD is 78.26%.
-
The Selling, General & Administrative Expenses for GILD have been equal to 21.18% of Gross Profit Margin.
-
The Research & Development expenses have been 20.54% of Revenue.
-
The Interest Expense is 203.54% of Operating Income.
-
The Net Earning history of GILD is 1.67% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 21 years.
Gilead Sciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | GILD |
CUSIP: | 375558 |
Website: | gilead.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.5 |
Quick Ratio: | 1.2 |
Price-to-Earnings
Trailing P/E Ratio: | 283.29 |
---|---|
Forward P/E Ratio: | 13.02 |
GILD Technical Analysis vs Fundamental Analysis
Buy
76
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy or a Sell?
-
Gilead Sciences stock is rated a BuyThe current Gilead Sciences [GILD] share price is $107.65. The Score for GILD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.